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Executive summary 
Bioprinting 
• There are a number of parameters that should be considered before undertaking a 
bioprinting project: cell viability, resolution, print speed, and 3D range. 
• Bioprinting is advantageous to scaffold-based tissue engineering due to precise 
placement of cells of multiple lineages. 
• Bioprinting presents a highly-reproducible method to create complex tissue-engineered 
constructs. 
Bioprinting approaches 
•  Four major bioprinting approaches and their applications are discussed: 
o Inkjet bioprinters are fast and inexpensive with high resolution, but are limited 
to low-viscosity bioinks and low cell-densities due to droplet-formation 
requirements.  
o Laser-assisted bioprinters have extremely high in-plane resolution, but are 
limited in the z-dimension. They are nozzle free, and are therefore able to print 
with high-viscosity fluids.  
o Extrusion-based bioprinters are inexpensive, and are especially suited to 
printing larger-scale constructs. They are able to print most gels, and are highly 
adaptable.  
o Stereolithographic bioprinting is not limited by bioink viscosities as there is no 
ejection, but currently they are only able to print one bioink at a time. Due to 
the use of light to crosslink, high-resolution prints may be achieved in all 
dimensions. Care must be taken to avoid cytotoxicity arising from UV-light 
exposure and photoinitiators.  
Bioink design 
• Discussion of popular bioinks and their applications: 
o Hydrogel-based bioinks are popular due to their biocompatibility; their porosity 
allows excellent oxygen and nutrient perfusion, and their morphologies are 
similar to that of natural extracellular matrices. They are typically easily 
extrudable and may be crosslinked under mild conditions. 
o Natural biopolymers such as collagen and gelatin may be used, but are more 
immunogenic than hydrogel-based bioinks. However, they present biochemical 
cues for processes such as adhesion, migration, and proliferation. 
o Composite bioinks may be used to combine benefits of different gels: 
▪ Pluronic F127 composites produce a thermally reversible gelation. This 
may be used to enhance printing of the hydrogel before being removed 
after crosslinking of other components. The shear thinning behaviour of 
Pluronic F127 may also be beneficial.  
▪ Alginate composites are easily and stably crosslinked under mild 
conditions with divalent metal ions such as calcium or barium. 
Challenges and future directions 
• Production of complex, hierarchical tissues with native-like mechanical properties is 
still problematic, in part due to the difficulty associated with vascularising tissues. 
• Adaptations of assays standardised for 2D tissue constructs can lead to spurious results. 
New techniques such as micro-CT and multiphoton microscopy must be adopted by the 
bioprinting community to produce comparable results. 
• The catalogue of cell-compatible bioinks needs to be expanded to address properties 
beyond viability and proliferation such as adhesion and migration. 
 
  
1. Bioprinting 
Bioprinting is emerging as the premier technique for the construction of complex 3D tissue-
like architectures. To a large extent, the expeditious progress in bioprinting can be reconciled 
by the strong coupling of the technique with advances in automated spatial control systems and 
rapid prototyping.  Moreover, the foundation science developed for 2D printing (e.g. inkjet, 
laser) has provided the inspiration for several analogous approaches in bioprinting. These 
approaches have relative advantages and disadvantages, which can be parameterised by 
considering several key factors, including cell viability, resolution, print speed, and 3D range. 
Accordingly, the new user must carefully consider which technique is most appropriate for 
their target tissue system. For example, approaches that favour high in-plane resolution are 
likely to be most appropriate for structures such as skin or membranes. Conversely, high-
resolution–slow-printing techniques may favour situations where the cells are extremely 
precious. 
Scaffold-based tissue engineering allows the crude geometry of a tissue construct to be defined 
and cell–biomaterial interactions to established, but it does not provide a mechanism for the 
precise placement of cells for the generation of complex hierarchical tissue, nor does it allow 
for the rapid assembly of macroscopic tissue morphologies. Conversely, bioprinting provides 
the opportunity for the fine tuning of structure and the addition of multiple cell lineages and 
other components in pre-determined sites in the same construct without using scaffolds.[1] 
Perhaps the most exciting potential application of bioprinting is the engineering of tissue and 
organs. Here, the high throughput, flexible bottom-up approach provides a mechanism to 
fabricate 3D cell patterns and tissue-like structures with multiple cell types.[2] Moreover, 
bioprinting provides a possible future solution to the problems associated with creating large 
vascularised tissues and organs. Previous methods of vascularisation have focussed on a single 
approach, such as scaffolds, cells, or growth factors, with limited success.[3] Printing directly 
with cells allows complex vascular structures such as veins to be printed simultaneously with 
the rest of the surrounding tissue construct.[2]  
In bioprinting, living cells, biomaterials and associated biochemical cues are precisely 
positioned layer-by-layer to fabricate 3D tissue structures. Spatial control of the functional 
components is of the upmost importance when attempting to recapitulate functional tissues 
with in vivo-like biological function and mechanical properties. Moreover, this automated 
approach offers a new way of producing highly scalable and reproducible tissue-engineered 
constructs, which are likely to pave the way for the development of new organ-on-chip models 
for big pharma. However, there are still major challenges associated with 3D bioprinting that 
must be overcome, such as the ability to adapt printing technologies designed to fabricate with 
plastic and metals for the printing of sensitive cells and biomaterials. To this end, new 
hydrogel-based bioinks are currently being developed, which support cell growth, and can be 
extruded to fabricate complex stable 3D structures. Perhaps the greatest challenge in the 
bioprinting field, and indeed the tissue engineering field, is the reproduction of the 
sophisticated, hierarchical cell and extracellular matrix (ECM) structures in organs; this has 
been extensively reviewed by Murphy and Atala,[4] and Kim et al.[5] Although this holy grail 
of regenerative engineering appears to be a long way off, it is likely that bioprinting will feature 
heavily in the eventual realisation of this ultimate goal. 
In this review, we summarise the current state-of-the-art in bioprinting through a description 
of the various approaches to bioprinting, both conceptual and technical. In doing so, we 
highlight advantages and disadvantages of the various techniques, which should inform the 
reader who is new to the field. This is followed by a brief discussion centred predominantly on 
composite hydrogel-based bioinks, looking at both naturally derived and synthetic gelling 
agents. We conclude with a look at the major challenges still ahead for the broader 
biofabrication community.  
2. Bioprinting approaches 
2.1 Conceptual differences 
There are several different conceptual bioprinting approaches that fall broadly into three 
categories: biomimicry, directed-assembly and tissue building block construction (Fig. 1) In 
biomimicry, the bioprinting process aims to reproduce the cellular and ECM components of 
tissue. In practice, this is achieved by reproducing specific 3D structures and cellular 
components that simulate the target tissue.[6] For example, a number of approaches seek to 
mimic the branching networks of vasculature, or by recreating growth factor gradients to 
generate the cartilage to bone transition.[7] Here, to accurately mimic the tissue, the 
microenvironment, including placement of cells, mechanical forces, gradients of biomolecules 
and ECM composition needs to be carefully considered, so that the tissue can be replicated on 
the microscale.[4] 
Directed-assembly approaches use embryonic development as a guide, wherein self-
assembling cellular spheroids that undergo cellular organisation are fabricated.[8] These cell 
aggregates already display appropriate cell signals and biomolecule secretions such that the   
cells organise and fuse, mimicking developing tissues.[9] This approach relies on the inbuilt 
programming of the cells to drive the self-organisation of the tissue, meaning that an in-depth 
knowledge of developmental mechanisms of embryonic tissue is required.[10] 
Finally, tissue building block construction involves assembly of the smallest structural 
functional components of tissues, for examples the nephron in the kidney.[11] These building 
blocks can then be assembled into larger structures by placement, fusion or both.[12] One 
approach is the self-assembly of cell spheroids, which are printed next to each other and fused 
to create a macro-tissue.[13] These have been used to create vasculature by fusing spheroids 
in branched vascular networks, and to create organ-on-a-chip models.[14] 
2.2 Bioprinting Techniques 
The four predominant techniques used for bioprinting are inkjet, extrusion, stereolithography, 
and laser-assisted printing (Fig. 2). As discussed above, each has advantages and disadvantages 
with respect to resolution, speed, cell viability and print height.  
2.2.1 Inkjet Bioprinting 
Inkjet-based bioprinting was developed in the early 2000s and was one of the first approaches 
used for biofabrication.[15] The first inkjet bioprinters were modified desktop 2D ink-based 
printers, where the ink cartridge was simply replaced with a cartridge containing cells and 
biomaterials (bioink).[16] Here, the bioink was expelled from a noncontact nozzle, using 
thermal pressure or piezoelectric pulses to create a droplet (Fig. 3). In general, inkjet-based 
bioprinters have a high resolution, low cost and high speed. A variety of droplet sizes have 
been printed, from less than 1 pL to more than 200 pL in volume,[17, 18] with rates of 1 – 
10,000 drops per second.[19] Moreover, single droplet printing has produced bioink line widths 
of less than 50 µm.[20]  
Thermal inkjet bioprinters use heat to generate a pressure pulse that forces droplets from the 
nozzle, where the localised heating does not significantly affect viability, and the printers have 
a high print speed, low cost and are extremely versatile.[21] However, there are a number of 
disadvantages, including non-uniform droplet size, fouling of the nozzle and incomplete cell 
encapsulation. Piezoelectric inkjet printers create acoustic waves inside the nozzle to eject 
droplets, where the parameters such as pulse, amplitude and wave duration can be controlled 
to change the size and rate of droplet ejection.[22] Shear stress can be reduced by using an 
open-pool system without a nozzle, reducing the loss of viability and preventing nozzle 
clogging.[19] However, the frequencies used by piezoelectric inkjet printers have the potential 
to damage cells and the printers have a limited number of materials that can be used as a bioink, 
due to the requirement for low viscosity fluids.[23] 
Examples of inkjet bioprinting include in situ approaches where fibroblasts and chondrocytes 
were printed directly into skin or cartilage wounds and the bioink was subsequently crosslinked 
via chemical or photo-initiated crosslinking.[24, 25] Inkjet bioprinting has been used to print 
bone constructs, which were grown in vitro before being implanted into mice. The bone 
constructs matured in vivo and produced tissue that was highly mineralised with similar density 
to natural bone tissue.[26] Inkjet printing has also been combined with electrospinning to make 
layered cartilage constructs that support cell function and have composite mechanical and 
structural properties.[7] 
In general, the bioinks for inkjet bioprinting need to be low viscosity liquids to allow 
microdroplet formation, which can be subsequently crosslinked or solidified to form 3D 
structures.[23] This somewhat limits the selection of bioinks that can be used. Moreover, 
chemical or light-induced crosslinking can reduce the overall print velocity and can be 
cytotoxic.[27] Another limitation of inkjet bioprinting is the low cell density (less than 10 
million cells mL-1), as increasing cell density to limits approaching biologically relevant cell 
densities inhibits droplet nucleation.[21] 
2.2.2 Laser-assisted Bioprinting 
Laser-assisted bioprinting (LAB) is modelled from laser-induced forward transfer, which was 
initially developed to print metals.[28] This is a less common form of bioprinting as the high 
cost of these systems is prohibitive for basic tissue engineering research.[4] LAB uses a pulsed 
laser beam which is focused on a donor support, usually made from glass, covered with an 
energy absorbing layer and a biological material layer. The laser pulses on the absorbing layer 
(gold or titanium) and a high-pressure bubble is nucleated that propels the biomaterial and cell 
layer towards the collector substrate. The process can deposit cell densities of around 108 cells 
mL-1.[29] High resolutions approaching single cells per droplet can be achieved with high 
deposition speeds of 1,600 mm per second.[30] This method is also nozzle-free, which enables 
the usage of high-viscosity bioinks. 
LAB has been used to print skin constructs, depositing clinically relevant cell densities in 
layers, however it remains to be seen whether the system can be scaled to larger tissue 
sizes.[31] LAB has also been used in situ to print nanoparticles of hydroxyapatite in a 3 mm 
wide, 600 µm deep, mouse calvaria defect model.[32] Mammalian cells have been printed as 
50–100 µm stacks or as individual cells on a hydrogel substrate[33] and laser-based bioprinting 
has been used to make a cardiac patch of polyester urethane urea seeded with MSCs and human 
umbilical vein endothelial cells.[34]  
 Although LAB has an extremely high in-plane resolution, there are a number of disadvantages. 
For example, the heat from the laser energy may damage cells and affect their functionality if 
printing parameters are sub-optimal.[35] Accordingly, the cell viability in LAB is generally 
lower when compared to inkjet or extrusion-based bioprinting.[36] Moreover, LAB is severely 
limited in the third dimension, which defines the height of the bioprinted construct.[37] The 
preparation of the donor substrate, which often needs to be changed for each cell or hydrogel 
type, is time consuming.[4] It can also be difficult to accurately position cells on the collector 
substrate. Finally, there are often metallic residues present in the printed construct arising from 
vaporisation of the metallic absorption layer.[38] 
2.2.3 Extrusion Bioprinting 
Current bioprinting methods such as ink jet and laser-induced forward transfer (LIFT) often 
damage the cells[39] and have not yet been used to successfully produce large 3D 
structures.[40] Extrusion-based bioprinting is ideally suited to the fabrication of large tissue 
constructs. For example, in 2013 Campos et al. printed into a high-density hydrophobic fluid, 
which allowed an almost unlimited number of printed layers, resulting in reproducible and high 
fidelity structures.[40] Extrusion systems are also the most cost effective bioprinters, and 
accordingly, academic institutions are increasingly using extrusion bioprinting technology in 
tissue engineering research.[41] Extrusion printers use pneumatic or mechanical pressure to 
deposit continuous filaments of materials rather than individual droplets, building up 3D 
structures layer-by-layer.[4] Mechanically-aided extrusion using a piston or screw-drive 
system generally provides high levels of control of the bioink flow through the nozzle, which 
is essential for bioinks with high viscosities.[42] However, in certain cases, mechanical 
systems can generate large backpressures along the nozzle, which can be harmful to cells.[43] 
Pneumatic systems use air pressure to dispense the bioink, which can be adjusted to suit a range 
of viscosities. Structural integrity of extruded bioink structures are generally better than the 
other techniques, due to deposition of continuous filaments, and physiological cell densities 
have been used to bioprint tissue-like structures.[35] It is therefore considered the most 
convenient, inexpensive and facile technique for bioprinting 3D cell-laden constructs. 
Extrusion bioprinting has been used to deposit hepatocytes and adipose-derived stromal cells 
in gelatin/chitosan hydrogels to engineer liver tissue constructs.[44] Here, channels were 
created throughout the constructs to allow the delivery of nutrients and removal of waste from 
the cells. These bioprinted structures retained structural integrity for over 2 months in culture, 
with a cell survival rate of over 95%. Sun and colleagues printed rat heart endothelial cells in 
an alginate hydrogel that were able to proliferate six fold to infill the hydrogel scaffold.[45] 
Perhaps the most exciting application of extrusion bioprinting is the fabrication of branching 
vascular networks. Forgacs and colleagues achieved this by extruding multicellular spheroids, 
layer-by-layer, with supporting agarose rods.[46] The spheroids fused post printing into 
double-layered vasculature tubes of 0.9 to 2.5 mm in diameter (Fig. 5).  
Vasculature bioprinting has also been achieved using fugitive inks, which can be removed by 
reverse temperature-dependent crosslinking, leaving behind a channel that can be seeded with 
endothelial cells.[47] Alternatively, coaxial needles can be used to print vasculature by printing 
alginate-based, endothelial cell-seeded bioink through the outer nozzle, and a calcium-
containing solution or fugitive ink through the inner nozzle.[48] Lewis and co-workers 
developed a fugitive Pluronic F127 (F127) ink that was used to print vasculature networks that 
were embedded in a gelatin methacrylate (GelMA) bulk matrix containing human neonatal 
dermal fibroblasts (HNDFs). The F127 was then removed by cooling the constructs below 4°C 
and the open channels were seeded with human umbilical vein endothelial cells (HUVECs). In 
2016, the Lewis group took this one step further by bioprinting renal proximal tubules on 
chips.[49] These open lumens were seeded with proximal tubule epithelial cells (PTECs) and 
after being perfused with medium, formed a tissue-like polarized epithelium. Other groups 
have demonstrated angiogenesis within fibrin networks by sprouting endothelial cells.[50, 51] 
These techniques should enable media exchange systems to be developed and allow thicker 
tissues to be fabricated in the future. Another considerable advantage to extrusion-based 
bioprinting is the range of compatible materials and viscosities. However, the identification of 
appropriate materials and bioinks then becomes a major challenge, which is discussed below. 
2.2.4 Stereolithographic bioprinting 
Stereolithographic (SLA) and projection stereolithographic (PSL) bioprinting use photocurable 
bioinks to form constructs via exposure to either lasers or projections (PSL). These systems 
can print structures with 50 μm resolution,[52] and produce constructs with >90% cell 
viability.[53] PSL technology allows a complete layer to be printed at once, and so print times 
depend only on layer thickness.[52]  
Bioink formulations for SLA bioprinting require a photoinitiator to produce free radicals for 
polymerisation, and suitable monomers. Many photoinitiators are cytotoxic, particularly due 
to the production of reactive oxygen species. Although 2-hydroxy-1-[4-
(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959) has been shown to cause 
minimal cell death across several cell types,[54] the ultraviolet (UV) light irradiation required 
for crosslinking can have adverse effects on viability and proliferation, and can cause DNA 
damage.[55] Accordingly, Wang et al. developed a visible-light sensitive photocurable bioink 
containing 2′,4′,5′,7′-tetrabromofluorescein disodium salt (eosin y) as a photoinitiator (Absmax 
@ 517 nm) to mitigate this risk.[52]  
Methacrylated polymers frequently used to generate crosslinkable hydrogels include alginate 
methacrylate,[56] GelMA,[57] and hyaluronic acid methacrylate (HA–MA).[58] Here, the 
degree of methacrylation can be tuned to alter the mechanical properties of the crosslinked 
hydrogel.[56, 57]  
A major advantage of SLA is that the print quality is to a large extent unaffected by the 
rheological properties of the bioink as there is no extrusion and the printed structures are 
supported by the surrounding bioink reservoir. However, this makes multi-material SLA 
printing almost impossible within a single process, limiting the ability to print complex tissues. 
It is possible to perform sequential prints with different bioinks, as demonstrated by Zhu et al. 
who produced prevascularised tissue contracts.[59]  
3. Bioink design 
The development of suitable bioinks remains one of the most challenging aspects of the 
bioprinting field. Here, cells must be suspended within a fluid to form a bioink, which needs 
to fulfil multiple requirements. The bioink must supply sufficient biological cues and 
mechanical support for the cells, but must also meet the physical and mechanical demands to 
complete the bioprinting process, known as ‘printability’.[35] Often these requirements are in 
conflict, as a material that can be extruded from a nozzle and undergo a transition to form a 
solid 3D structure, may not be cytocompatible. Moreover, different cell types may be more or 
less sensitive to constituents in the bioink formulation, which can create problems when more 
than one cell type is being used in the same construct.   
3.1 Hydrogel-based bioinks 
Hydrogels are excellent candidates for 3D cell culture and bioink design.  They exhibit similar 
morphologies to some ECMs (soft to medium tissue) and have tuneable mechanical properties. 
Perhaps most importantly, hydrogels are stabilised by networks of water-swollen polymers that 
can be crosslinked by either covalent or non-covalent intra- and intermolecular attractions.[60] 
The ability to absorb large quantities of water (99% w/w), coupled with their porous network 
structure, make hydrogels an extremely attractive class of materials for regenerative 
engineering.[61, 62] Moreover, hydrogels are largely biocompatible, with high oxygen and 
nutrient permeability making them ideal for cell encapsulation. Hydrogel materials are also 
injectable/extrudable, and many of the crosslinking methodologies are mild enough to be 
carried out in the presence of living cells.[63] Hydrogels can be biodegraded in a controlled 
manner, and properties such as swelling and crosslinking can be influenced by their 
environment, for example through changes in temperature, ionic strength, pH, and shear. 
Generally, a hydrogel bioink will have a temporal crosslinking mechanism such that a self-
supporting structure can be built up layer-by-layer. Moreover, it must be biocompatible, not 
elicit an immune response, have short and long term stability, and have the ability to be 
remodelled by cellular processes. The bioink should also support cell function, and in some 
cases, it is beneficial to have material constituents that support cellular attachment and 
proliferation.[4] Many hydrogel bioinks are shear-thinning, allowing them to be extruded 
through a nozzle, yet hold their shape in a 3D structure. 
3.2 Natural biopolymer components for hydrogel bioinks 
Biogenic polymers have long been used to synthesise hydrogels for tissue engineering, due to 
their inherent biocompatibility and functionality. Hydrogels have been constructed from 
proteins, polysaccharides and DNA, however, their widespread adoption is somewhat 
restricted due to immunogenicity and poor mechanical properties. Some of the most commonly 
used proteins in hydrogels for tissue engineering are collagen and gelatin. Collagen is 
biodegradable and abundant in mammalian tissue, meaning it can be sourced readily.[64] 
Gelatin is a denatured form of collagen, is less immunogenic, and promotes cellular adhesion, 
migration and proliferation.[57] Another commonly used hydrogel for tissue engineering is 
Matrigel, a gelatinous protein hydrogel secreted by Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma cells.[65] Matrigel is composed of laminin and collagen type IV, as well as many 
other proteins and growth factors, and it is widely used as a 3D scaffolding material due to its 
wide spectrum cytocompatability.[66] However, the complex and somewhat poorly defined 
composition of  Matrigel can introduce variability in experimental results.[67] 
Polysaccharides such as hyaluronic acid (HA), heparin, chitosan, and alginate have been used 
to produce hydrogels for tissue engineering.[68, 69] HA is an ECM component made from 
glycosaminoglycans (GAGs), which is a major constituent of connective tissue, and it plays a 
vital role in processes such as nutrient diffusion, hydration and cell differentiation. However, 
HA structures often have to be modified, either through coating with cell-adhesive 
biomolecules or by treating with UV light, to increase cell attachment due to the smooth surface 
and anionic charge.[70] In general, polysaccharides are attractive due to their chemical 
addressability, where functional groups such as acrylate and amines can be easily and 
efficiently introduced, which can drive hydrogel formation and provide sites for bioconjugate 
chemistry.[71] In addition, polysaccharide hydrogels can be combined with proteins such as 
collagen[72] and fibrin[73] to form composite hydrogels, with composite mechanical 
properties. 
A variety of different hydrogels based on constituents derived from eukaryotes are used in 
extrusion bioprinting, including Matrigel, collagen I,[1] and synthesised gels such as 
GelMA.[47] By utilising these naturally occurring gelation agents, it is possible to generate 
microenvironments displaying many copies of ECM specific sequences. For example, collagen 
forms a hydrogel at physiological temperatures and pH by triple helix formation, and has RGD 
sequences that stimulate cell adhesion.[74] Conversely, gelatin has a partially unfolded triple 
helix, which imparts thermo-responsive properties, forming a gel at around 30°C.[75] 
Hyaluronic acid is a glycosaminoglycan found in the ECM, which can be modified to introduce 
crosslinkable moieties.[76] Generally, bioinks constituted from natural polymers are preferred, 
due to their inherent biocompatibility, however synthetic polymers such as poly(ethylene) 
glycol (PEG) are also used in bioprinting, and can be modified with binding sequences, such 
as RGD, to increase cellular adhesion.[77] 
3.3 Composite, hybrid bioinks 
This composite or hybrid approach to gel formation represents a promising new way to improve 
the printability and persistence of bioinks without sacrificing biocompatibility.[78] In general, 
high-viscosity gels provide the printed construct with structural support and low-viscosity gels 
provide a better environment for cell viability and function.[4] Accordingly, a variety of 
composite bioinks have been reported, including collagen/fibrin gels and alginate/gelatin 
gels.[79] Composite gels can either be deposited on top of one another, often to induce 
crosslinking, or mixed together before printing.  Li et al. developed a two-nozzle inkjet-based 
bioprinter that combined two DNA-based hydrogels.[80] One hydrogel was a polypeptide-
DNA conjugate and the second was double stranded DNA with sticky ends, the sticky ends 
being complementary to the DNA polypeptide sequences of the first bioink. This meant when 
the two bioinks were printed on top of one another the solution crosslinked, cells were 
encapsulated and were viable after 48 hours. Rutz et al. used a PEGX crosslinker with gelatin, 
fibrinogen, GelMA, PEG amine and other gels, to create a range of bioink formulations.[81] 
Gels that were strongly crosslinked were unable to be extruded, but softer gels could be built 
up into hydrogel constructs. PEGX crosslinking allowed properties of the bioink to be 
controlled, such as viscosity and biodegradability. 
The combination of hydrogels to create a composite bioink can confer useful properties from 
both hydrogels. Markstedt et al. combined shear-thinning properties of nanofibrillated 
cellulose with fast crosslinking of alginate and the resultant hydrogel printed constructs were 
stable over 7 days.[82] A composite alginate, gelatin and hydroxyapatite hydrogel was shown 
to have both instantaneous and long-term structural stability, conferred by a two-step printing 
mechanism combining the thermosensitive response of gelatin with the alginate chemical 
crosslinking.[83] The addition of gelatin increased the viscosity of the bioink and improved 
print fidelity. HA–MA and thermosensitive polymer poly(N-isopropylacrylamide) 
(pNIPAAM) have been combined to increase mechanical integrity.[58] HA–MA has a low 
viscosity and cannot be printed by itself, therefore pNIPAAM was conjugated to HA–MA to 
make HA–pNIPAAM, which acted as a thermoresponsive structural support, while the HA–
MA could be crosslinked, after which the HA–pNIPAAM was washed away. 
3.3.1 F127 composite bioink systems 
Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO; Pluronic®) 
copolymers form temperature responsive materials that have been widely studied for 
biomedical applications.[84] Pluronics or poloxamers are water soluble, biocompatible and 
certain molecular weights are FDA approved.[85] F127 is one such poloxamer, which when 
dissolved in water at high concentrations (≥16 wt%), exhibits a temperature dependent sol–gel 
transition at physiological temperatures.[86] The sol–gel transition results from the formation 
of nanoscale micelles via hydrophobic interactions, which are closely packed when the 
temperature rises above the low critical solution temperature (LCST), resulting in a change of 
rheological properties. At low temperatures the block copolymers exist as dissolved monomers 
in solution, but self-assemble into micelles under conditions defined by the critical micelle 
temperature (CMT) at constant concentration and critical micelle concentration (CMC) at 
constant temperature. This reversible sol–gel transition, along with the micelles ability to 
solubilise hydrophobic solutes, has generated interest in using F127 for injectable carriers for 
drug delivery.[87] 
Although F127 is biocompatible and non-cytotoxic, it is known to be poorly adhesive to cells, 
and has to be modified with anionic polymers such as poly(acrylic acid) (PAA) to improve 
cellular adhesion.[84] Pluronic hydrogels also show low mechanical strength, rapid 
degradation and fast drug release in vivo, due to dilution of the hydrogel and therefore lowering 
of the concentration to below the CMC.[86] Therefore, chemical modifications or combination 
with other polymers and hydrogels is needed to enhance stability and adhesion properties. 
F127 has received recent renewed attention as a bioink constituent due to its predictable 
temperature-dependent sol–gel transition. As discussed above, Lewis and colleagues used it as 
a fugitive ink to templates vessel structures, before washing away.[47] Armstrong et al. used 
F127 as a fugitive component in their bioink to produce microporous structures capable of 
producing bone and cartilage tissues.[88] Kang et al. used a multi-head bioprinter to fabricate 
an interwoven scaffold of polycaprolactone (PCL) and F127, where the F127 acted as a 
sacrificial material.[89] Here, the bioink was also printed at the same time, comprising gelatin, 
fibrinogen, HA and glycerol. Gelatin was included to improve the viscosity of the bioink, 
whereas fibrinogen afforded good cell adhesion. The fibrinogen was crosslinked using 
thrombin before the F127, gelatin, HA and glycerol were removed by washing. F127 has also 
been used in bioprinting for cardiovascular applications, mixed with collagen I to enable a 
double gelling system.[43]  
F127 exhibits good shear thinning behaviour, which is advantageous for extrusion bioprinting, 
due to shear-induced back pressures. Pluronic hydrogels have also been shown to produce 
nanostructures when combined with other hydrogels, such as PEG-Fibrinogen, which increases 
the storage modulus of the hydrogels.[90, 91] Muller et al. used this property to combine 
diacrylated Pluronic F127 (PF127-DA) with F127 at a high concentration to print with 
chondrocytes.[92] After bioprinting and photoinitiated crosslinking of the PF127-DA, the F127 
component was washed away leaving behind a nanoporous hydrogel. Interestingly, they found 
that the F127 sterically hindered photoinduced crosslinking of other hydrogel combinations, 
such as HA–MA. Cells were viable for 14 days in the bioink, however the hydrogel was still 
relatively weak, with a compressive modulus of just 1.5 kPa. 
3.3.2 Alginate as a bioink constituent 
Alginate is a naturally occurring polysaccharide normally obtained from brown algae which 
has been used extensively in many industries, such as food, textiles and pharmaceuticals, 
because of its biocompatibility, low cost and mild gelation.[93] Alginate consists of linear 
block copolymers of (1,4)-linked β-D-mannuronate (M) and α-L-guluronate (G) residues, 
which participate in crosslinking with divalent cations, such as Ca2+, and form hydrogels.[94] 
This gentle ionic crosslinking makes alginate hydrogels cytocompatible, and the gelation is 
reversible, meaning cell recovery is possible. A range of divalent cations can be used to 
crosslink alginate (calcium, magnesium, barium) and although it can be covalently crosslinked, 
most approaches use ionic crosslinking.[93] The most popular method of crosslinking involves 
the addition of using calcium chloride (CaCl2), which can give rise to limited long-term 
stability in aqueous media. Alternatively, immersion-bioprinting of alginate into a CaCl2 bath 
causes the alginate to crosslink immediately upon extrusion, allowing the printing of 
overhanging structures. Hinton et al. printed into a bath of CaCl2-doped gelatin slurry to 
crosslink the alginate bioink whilst providing support to give excellent structural fidelity (Fig. 
6).[95] Commercial alginate-based hydrogel kits are available, such as the NovaMatrix-3D cell 
culture system, which has air-dried alginate foams contained in well plates which can be mixed 
with culture media and cells to create hydrogels.[96] 
Cells normally have a rounded morphology in alginate hydrogels, and unlike collagen or fibrin, 
alginate hydrogels are normally modified with adhesive biomolecules, such as RGD, to 
facilitate cell attachment and spreading.[97] Though in some cases, such as cartilage tissue 
engineering, the rounded morphology can be an advantage.[98] Alginate is used extensively in 
cell and tissue culture due to its lack of receptors and low protein adsorption, meaning the 
hydrogels serve as a “blank slate”.[93, 99] Highly specific amounts of biomolecules can then 
be incorporated to study the effect of particular cellular adhesion receptors or growth factors. 
For example, MSC differentiation was shown to be controlled by RGD–alginate gels’ elastic 
moduli, where more rigid gels promoted osteogenesis, and less rigid gels promoted 
adipogenesis.[97] Tumour microenvironments have also been studies using alginate gels, 
RGD–alginate gels altered cancer cell signals in recruiting blood vessels, which could pave the 
way to developing new anti-angiogenic cancer treatments.[100] 
Sodium alginate has been used as a component bioink in many different applications.[82, 101, 
102] Jia et al. bioprinted adipose-derived stem cells lattice structures using oxidised alginate 
hydrogels to control the degradation rate of the bioink. In general, however, the printability, 
cell viability and mechanical properties of alginate bioinks are often not stable unless cross-
linked using CaCl2.[103] Shu and colleagues used a three stage crosslinking process to inkjet-
print U87-MG human brain tumour cells for cancer disease models.[104] Firstly, the gel was 
crosslinked with calcium ions before printing to generate the flow properties for the 
bioprinting, secondly the alginate was crosslinked immediately after printing for to increase 
stiffness, and finally barium ions were used to crosslink for long term stability. This gave way 
to tubular structures with a minimum diameter of 7.7 mm with cell high viability over 11 days 
of culture. 
By combining alginate with other gels, such as gelatin, the properties of alginate can be 
enhanced and well-defined structures can be printed.[7, 101] Often printed cells cannot degrade 
surrounding alginate matrices, causing them to proliferate poorly and remain 
dedifferentiated.[105] To counter this problem alginate has been combined with collagen and 
gelatin to print human corneal epithelial cells (HCECs) in macroporous structures.[106] Cell 
viability was over 90% and degradation of the constructs could be controlled using 
concentrations of sodium citrate.  
4. Challenges and future directions  
Bioprinting represents a facile and reproducible path for the rapid construction of tissue-like 
constructs and is quickly emerging as the must-have tool for the tissue engineer. That being 
said, many of the challenges associated with scaffold-based tissue engineering still remain. For 
example, there are few if no examples of bioprinted 3D tissue constructs exhibiting the 
complex hierarchical structures or mechanical properties of native ECMs, even for avascular 
tissue such as cartilage. Although examples of printed constructs containing perfusable 
vasculature are starting to emerge, these are still rather primitive when compared with the 
genuine article.  
The development of standardised assays for the phenotypic interrogation of bioprinted 
constructs is also a major challenge. Essentially, all the in vitro-based assays have been 
developed for 2D culture and adapting these to 3D culture models can be challenging. For 
example, the presence of the bioink may give rise to spurious results when using fluorescence-
based approaches. Moreover, the majority of microscopes available to the user have limited 
working distances. Accordingly, the field must work hard to address this issue by embracing 
new experimental methodologies, both instrumental (e.g., two-photon, micro- and nano-CT) 
and chemical (e.g., new probes and antibodies) if it is to build a body of literature with 
comparable data.    
The range of cell-compatible bioinks is now starting to expand to a level that meets the needs 
of most cell types, and contains constituents that are derived from eukaryotes, other biota or 
purely synthetic origins. However, the biocompatibility of bioinks are predominantly 
benchmarked by cell viability and proliferation, with little emphasis placed on cell adhesion 
and motility. Accordingly, if more complex tissue architectures displaying ECM structures are 
to be realised, these other factors that affect cell fate must be built in to the design philosophy.   
The large number of challenges that need to be overcome may make the bioprinting of organs 
seem to be a far-off goal. However, the technology is still extremely new and the rate of 
development over the last five years has been staggering. It is an extremely exciting field to 
work in, and bioprinting is perhaps the most inherently interdisciplinary research area. With 
that in mind, it is essential that a convergent approach be used to assemble the best research 
team, where chemists, engineers, biologists and medical practitioners are all focussed on 
achieving the global objective of functional synthetic tissue.  
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 Figure 1. Three current bioprinting approaches: biomimicry aims to recapitulate tissue macro- and micro-
structures with cells and ECM components in the bioink; directed assembly uses cell aggregates to form structures 
before assembly structures; tissue building-block construction involves co-culturing cell types to form micro-
tissues that can then be assembled. 
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Figure 2. The main bioprinting technologies: microextrusion bioprinters use a piston, air pressure, or screw drives 
to extrude material; inkjet bioprinters use thermal or piezoelectric actuators to emit droplets, or Rayleigh 
instability of a continuous flow through a small orifice; laser-assisted bioprinters use a laser focused on an energy 
absorbing substrate to propel biomaterials and cells onto a collecting plate; photocuring bioprinters use light to 
polymerise the surface of bioink reservoirs.  
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Figure 3. Cell-laden bioink being ejected from an inkjet nozzle. Reprinted with permission from Wiley 
Periodicals, Inc.[107]  
  
 Figure 4. Cardiac patch produced via laser-assisted bioprinting. (A) Micropatterned hMSCs (red) and hUVECs 
(green). (B) Cardiac patch implanted into rat myocardium. Reprinted with permission from Elsevier Ltd.[34] 
  
  
Figure 5. Extrusion-based bioprinting of multicellular spheroids to produce vascular networks. (A) Spheroids 
deposited in hollow cylindrical pattern on day 0 and (B) day 7. (C) Printed branched vascular network with 1.2 
mm diameter (solid arrow) and 0.9 mm (dashed arrow) branches on day 0 and (D) day 6. Reprinted with 
permission from Elsevier Ltd.[46] 
  
Figure 6. Embryonic chick heart printed in 
alginate. (A) Dark field image embryonic chick heart. (B) The heart stained for fibronectin (green), nuclei (blue) 
and f-actin (red), and imaged using confocal microscopy. (C) Cross section of the CAD model based on the 
confocal data. (D) Cross section of the printed heart in fluorescent alginate. (E) Dark field image of the printed 
heart. Scale bars: 1mm (A,B) and 1 cm (D,E). This work is licensed under the Creative Commons Attribution 4.0 
International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ or send a 
letter to Creative Commons, PO Box 1866, Mountain View, CA 94042, USA.[95] 
 
 
 
 
